| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $42.96B | -3.7% |
| Cost of Revenue | $38.36B | -3.5% |
| R&D Expense | $810.0M | -2.3% |
| SG&A Expense | $1.58B | -2.8% |
| Interest Expense | $811.0M | +8.7% |
| Pre-tax Income | $1.60B | +143.9% |
| Income Tax | $399.0M | — |
| Net Income | $1.20B | +82.0% |
| EPS (Basic) | $1.57 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.19B | -26.7% |
| Accounts Receivable | $4.76B | +0.8% |
| Inventory | $6.54B | +7.7% |
| Current Assets | $16.59B | -5.8% |
| Total Assets | $57.31B | -1.1% |
| Current Liabilities | $10.29B | +3.3% |
| Long-term Debt | $15.71B | +5.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.91B | -43.9% |
| Investing Cash Flow | -$2.37B | +19.1% |
| Financing Cash Flow | -$1.17B | +62.5% |
| +91.5% |
| EPS (Diluted) | $1.57 | +91.5% |
| Stockholders' Equity |
| $17.36B |
| -6.7% |